Family Files Granuflo Lawsuit After Woman Dies

In September, a Nevada resident filed a lawsuit against Fresenius Medical Care, alleging that her mother died as a result of the dangerous side effects from the widely prescribed dry acid product used in dialysis, Granuflo.

Francis Early was reportedly given the acidic concentrate and developed metabolic alkalosis. She also suffered from arrhythmia and hypokalemia before dying in September 2011.

The product has been linked to cardiopulmonary arrest and death.

Last year, the U.S. Food and Drug Administration (FDA) issued a recall notice saying the products can “lead to a high serum bicarbonate level in patients undergoing hemodialysis,” saying, “[I]f not appropriately treated, may culminate in cardiopulmonary arrest. This product may cause serious adverse health consequences, including death.”

Following the recall, the New York Times reported that Fresenius was treating more than a third of the estimated 400,000 Americans receiving dialysis. The company is based in Germany.

In the Early lawsuit, the family claims that Fresenius altered the formula of Granuflo, increasing the sodium diacetate, without notifying the FDA. The lawsuit claims that Fresenius intentionally and negligently concealed the information from the agency and failed to warn healthcare facilities and workers.

ZK represents many individuals who received Granuflo.  If you would like more information, please feel free to contact ZK toll-free (888)-841-9623. or submit your inquiry online.

Zoll & Kranz, LLC –Legal advocates for medical drug/device safety & effectiveness

represents many individuals who were given Granuflo.

ZK’s ‘Did You Know?’: There are more than 2,700 Fresenius clinics worldwide.